Skip to content

The raw feed

Latest filings

Every transaction from every Form 4, as filed, newest first. Open-market buys (P) and sells (S) become signals; the rest is shown for completeness.

DateCompanyInsiderTransactionSharesPriceValueHoldings afterFiled
Sep 4, 2026LPSN
LIVEPERSON INC
Vanessa Pegueros
director
DDisposition to issuer
Common Stock
-22,663--041 d ago
Sep 2, 2026IQV
IQVIA HOLDINGS INC.
James G. Berkshire
See Remarks
DDisposition to issuer
Common Stock
-2,713$261.54$710k8,17741 d ago
Sep 4, 2026LPSN
LIVEPERSON INC
Ryan L. Vardeman
director
DDisposition to issuer
Common Stockindirect: See Footnotes
-44,422--041 d ago
Sep 4, 2026LPSN
LIVEPERSON INC
Ryan L. Vardeman
director
DDisposition to issuer
Common Stock
-23,350--041 d ago
Sep 4, 2026LPSN
LIVEPERSON INC
Monica L. Greenberg
EVP, Policy & General Counsel
DDisposition to issuer
Common Stock
-32,550--43,34441 d ago
Sep 4, 2026LPSN
LIVEPERSON INC
Monica L. Greenberg
EVP, Policy & General Counsel
DDisposition to issuer
Common Stock
-43,344--041 d ago
Sep 4, 2026LPSN
LIVEPERSON INC
Monica L. Greenberg
EVP, Policy & General Counsel
DDisposition to issuer
Stock Option (Right to Buy)derivative
-18,902--041 d ago
Sep 4, 2026LPSN
LIVEPERSON INC
James R. Miller
director
DDisposition to issuer
Common Stock
-22,196--041 d ago
Sep 4, 2026LPSN
LIVEPERSON INC
William Wesemann
director
DDisposition to issuer
Common Stock
-43,655--041 d ago
Sep 4, 2026LPSN
LIVEPERSON INC
William Wesemann
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-7,067--041 d ago
Aug 12, 2026ETOR
eToro Group Ltd.
Santo Politi
director
DDisposition to issuer
Class A common sharesindirect: By Spark Capital II, L.P.
-3,559,007$0.00$0041 d ago
Aug 12, 2026ETOR
eToro Group Ltd.
Santo Politi
director
DDisposition to issuer
Class A common sharesindirect: By Spark Capital Founders' Fund II, L.P.
-23,280$0.00$0041 d ago
Sep 4, 2026LPSN
LIVEPERSON INC
Anthony Zingale
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-26,666--041 d ago
Sep 2, 2026ADXN
Addex Therapeutics Ltd.
Lenaic Nathanael Teyssedou
PRINCIPAL ACCOUNTING OFFICER
DDisposition to issuer
Stock-option (Right to Buy)derivative
-37,770$0.00$0565,13841 d ago
Sep 2, 2026ADXN
Addex Therapeutics Ltd.
Lenaic Nathanael Teyssedou
PRINCIPAL ACCOUNTING OFFICER
DDisposition to issuer
Stock-option (Right to Buy)derivative
-59,530$0.00$0543,37841 d ago
Sep 2, 2026ADXN
Addex Therapeutics Ltd.
Lenaic Nathanael Teyssedou
PRINCIPAL ACCOUNTING OFFICER
DDisposition to issuer
Stock-option (Right to Buy)derivative
-10,000$0.00$0592,90841 d ago
Sep 2, 2026ADXN
Addex Therapeutics Ltd.
Lenaic Nathanael Teyssedou
PRINCIPAL ACCOUNTING OFFICER
DDisposition to issuer
Stock-option (Right to Buy)derivative
-30,000$0.00$0572,90841 d ago
Sep 2, 2026ADXN
Addex Therapeutics Ltd.
Lenaic Nathanael Teyssedou
PRINCIPAL ACCOUNTING OFFICER
DDisposition to issuer
Stock-option (Right to Buy)derivative
-65,620$0.00$0537,28841 d ago
Sep 2, 2026ADXN
Addex Therapeutics Ltd.
Lenaic Nathanael Teyssedou
PRINCIPAL ACCOUNTING OFFICER
DDisposition to issuer
Stock-option (Right to Buy)derivative
-90,529$0.00$0512,37941 d ago
Sep 2, 2026ADXN
Addex Therapeutics Ltd.
Lenaic Nathanael Teyssedou
PRINCIPAL ACCOUNTING OFFICER
DDisposition to issuer
Stock-option (Right to Buy)derivative
-208,974$0.00$0393,93441 d ago
Sep 2, 2026ADXN
Addex Therapeutics Ltd.
Lenaic Nathanael Teyssedou
PRINCIPAL ACCOUNTING OFFICER
DDisposition to issuer
Stock-option (Right to Buy)derivative
-100,485$0.00$0502,42341 d ago
Sep 2, 2026ADXN
Addex Therapeutics Ltd.
Mikhail Kalinichev
HEAD OF TRANSLATIONAL SCIENCE
DDisposition to issuer
Common Stock
-306,765$0.00$0041 d ago
Sep 2, 2026ADXN
Addex Therapeutics Ltd.
Mikhail Kalinichev
HEAD OF TRANSLATIONAL SCIENCE
DDisposition to issuer
Stock-option (Right to Buy)derivative
-200,000$0.00$0041 d ago
Sep 2, 2026ADXN
Addex Therapeutics Ltd.
Jason Raleigh Nunn
director
DDisposition to issuer
Common Stock
-219,561$0.00$0041 d ago
Sep 2, 2026ADXN
Addex Therapeutics Ltd.
Jason Raleigh Nunn
director
DDisposition to issuer
Stock-option (Right to Buy)derivative
-50,000$0.00$0041 d ago
Sep 2, 2026ADXN
Addex Therapeutics Ltd.
Roger Mills
CHIEF MEDICAL OFFICER
DDisposition to issuer
Common Stock
-392,837$0.00$0393,13941 d ago
Sep 2, 2026ADXN
Addex Therapeutics Ltd.
Roger Mills
CHIEF MEDICAL OFFICER
DDisposition to issuer
Stock-option (Right to Buy)derivative
-50,000$0.00$0041 d ago
Sep 2, 2026ADXN
Addex Therapeutics Ltd.
Isaac Manke
director
DDisposition to issuer
Common Stock
-219,561$0.00$0041 d ago
Sep 2, 2026ADXN
Addex Therapeutics Ltd.
Isaac Manke
director
DDisposition to issuer
Stock-option (Right to Buy)derivative
-50,000$0.00$0041 d ago
Sep 2, 2026ADXN
Addex Therapeutics Ltd.
Vincent Michael Lawton
director
DDisposition to issuer
Common Stock
-2,507,487$0.00$050041 d ago
Sep 2, 2026ADXN
Addex Therapeutics Ltd.
Vincent Michael Lawton
director
DDisposition to issuer
Stock-option (Right to Buy)derivative
-501,598$0.00$0041 d ago
Sep 2, 2026ADXN
Addex Therapeutics Ltd.
Raymond George Hill
director
DDisposition to issuer
Common Stock
-1,365,532$0.00$0041 d ago
Sep 2, 2026ADXN
Addex Therapeutics Ltd.
Raymond George Hill
director
DDisposition to issuer
Stock-option (Right to Buy)derivative
-273,107$0.00$0041 d ago
Sep 2, 2026ADXN
Addex Therapeutics Ltd.
Timothy Mark Dyer
CHIEF EXECUTIVE OFFICER
DDisposition to issuer
Common Stock
-16,413,787$0.00$0435,19241 d ago
Sep 2, 2026ADXN
Addex Therapeutics Ltd.
Timothy Mark Dyer
CHIEF EXECUTIVE OFFICER
DDisposition to issuer
Stock-option (Right to Buy)derivative
-3,369,796$0.00$0041 d ago
Mar 11, 2026SNDA
SONIDA SENIOR LIVING, INC.
Michael Simanovsky
director, owner
DDisposition to issuer
Series A Convertible Preferred Stockderivativeindirect: See footnotes
-38,742--041 d ago
Mar 11, 2026SNDA
SONIDA SENIOR LIVING, INC.
Michael Simanovsky
director, owner
DDisposition to issuer
Series A Convertible Preferred Stockderivativeindirect: See footnotes
-2,508--041 d ago
Mar 11, 2026SNDA
SONIDA SENIOR LIVING, INC.
Michael Simanovsky
director, owner
DDisposition to issuer
Warrantderivativeindirect: See footnotes
-968,538--041 d ago
Mar 11, 2026SNDA
SONIDA SENIOR LIVING, INC.
Michael Simanovsky
director, owner
DDisposition to issuer
Warrantderivativeindirect: See footnotes
-62,712--041 d ago
Aug 27, 2026MTRX
MATRIX SERVICE CO
David (james) Miller
VP & General Counsel
DDisposition to issuer
Common Stock
-1,702$10.91$19k25,97941 d ago
Aug 27, 2026MTRX
MATRIX SERVICE CO
David (james) Miller
VP & General Counsel
DDisposition to issuer
Common Stock
-1,607$10.91$18k25,31041 d ago
Aug 29, 2026MTRX
MATRIX SERVICE CO
David (james) Miller
VP & General Counsel
DDisposition to issuer
Common Stock
-2,370$10.83$26k24,67841 d ago
Aug 30, 2026MTRX
MATRIX SERVICE CO
David (james) Miller
VP & General Counsel
DDisposition to issuer
Common Stock
-967$10.83$10k23,74641 d ago
Sep 1, 2026REAX
Real REMAX Group Inc.
Ravi Jani
Chief Financial Officer
DDisposition to issuer
Restricted Stock Unitderivative
-248$0.00$07,53142 d ago
Sep 2, 2026MEI
METHODE ELECTRONICS INC
Stacie Schulz
Chief Accounting Officer
DDisposition to issuer
Common Stock
-1,649$18.10$30k9,81142 d ago
Sep 1, 2026FLUT
Flutter Entertainment plc
Daniel Mark Taylor
President FLUT; CEO FLUT Intl
DDisposition to issuer
Nil Cost Options (Right to Buy)derivative
-7,902--042 d ago
Sep 1, 2026FLUT
Flutter Entertainment plc
Daniel Mark Taylor
President FLUT; CEO FLUT Intl
DDisposition to issuer
Nil Cost Options (Right to Buy)derivative
-5,639--042 d ago
Sep 1, 2026RSI
Rush Street Interactive, Inc.
Richard Todd Schwartz
Chief Executive Officer
DDisposition to issuer
Class V Voting Stock10b5-1
-47,222$0.00$05,089,99742 d ago
Sep 1, 2026RSI
Rush Street Interactive, Inc.
Richard Todd Schwartz
Chief Executive Officer
DDisposition to issuer
Class V Voting Stockindirect: By Irrevocable Trust10b5-1
-55,555$0.00$0426,42942 d ago
Sep 1, 2026RSI
Rush Street Interactive, Inc.
Richard Todd Schwartz
Chief Executive Officer
DDisposition to issuer
Class V Voting Stockindirect: By Trust10b5-1
-55,555$0.00$0426,42942 d ago

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.